Abstract:Background: Preclinical studies have shown that brain-derived neurotrophic factor (BDNF) may be involved in antidepressant action, and the BDNF gene has been suggested to be involved in the pharmacological treatment of major depressive disorder (MDD). In this study, the relationship between BDNF Val66Met polymorphism (Single Nucleotide Polymorphism Database ID: rs6265) and severity of depression, efficacy of fluoxetine and its side effects was tested in Chinese patients with MDD. Methods: Patients with MDD took the oral selective serotonin reuptake inhibitor (SSRI) fluoxetine (20 mg/day) for 6 weeks. Its clinical efficacy and side effects were measured by the 17-item Hamilton Rating Scale for Depression and the Treatment-Emergent Symptoms Scale (TESS), respectively. The patients were genotyped for Val66Met polymorphism of the BDNF gene. Results: In the multivariate regression analysis, there was no significant association between severity of depression and BDNF Val66Met polymorphism. There was no association between efficacy of fluoxetine and BDNF Val66Met polymorphism, but there was a marginal positive suggestion that heterozygous patients tended to have a better remission with fluoxetine in comparison with homozygous analogs. Insomnia and decreased sexual desire, side effects of fluoxetine, may have an association with the BDNF Val66Met polymorphism, and Met allele carriers showed a lower incidence of these side effects. Conclusions: These results indicate that there was a lack of association between severity of depression and BDNF Val66Met polymorphism in Chinese patients with MDD. The BDNF Val66Met polymorphism may play a major role in the efficacy and side effects of SSRI (fluoxetine) in Chinese patients with MDD. Copyright (C) 2009 S. Karger AG, Basel

The BDNF Val66Met Modulates the Dark Triad: Empathic Concern and Aggression As Mediators

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

The BDNF Val66Met Polymorphism Impacts Victim's Moral Emotions Following Interpersonal Transgression.

Increased parasympathetic activity and ability to generate positive emotion: The influence of the BDNF Val66Met polymorphism on emotion flexibility

Dark Triad Traits Mediate the Interaction Between Childhood Abuse and COMT Val158Met Polymorphism on Aggression among Incarcerated Chinese Males

BDNF Val66Met polymorphism moderates negative symptom expression of bully victimization through resilience in Taiwanese youth

The BDNF Val66Met Polymorphism Interacts with Maternal Parenting Influencing Adolescent Depressive Symptoms: Evidence of Differential Susceptibility Model

Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

BDNF Val66Met Polymorphism and Anxiety/depression Symptoms in Schizophrenia in a Chinese Han Population.

Effect of Val66Met Polymorphism in BDNF on Attentional Bias in an Extroverted Chinese Han Population.

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

Effects of BDNF Val66Met Polymorphisms on Brain Structures and Behaviors in Adolescents with Conduct Disorder.

the Association of BDNF Val66Met Gene Polymorphism and Family Function

Cyberbullying Victimization and Psychopathological Symptoms among Adolescents Varied in BDNF Val66Met Polymorphism and Vagal Tone

Association of BDNF gene polymorphism with major depression and cognitive functions

Genetic Variant Bdnf (val66met) Polymorphism Alters Anxiety-Related Behavior

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders

Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation

The BDNF Val66Met Gene Polymorphism is Associated with Increased Alexithymic and Anticipatory Anxiety in Patients with Panic Disorder.